The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Cigna's Evernorth business caps GLP-1 drug copays at $200 or less ... monthly out-of-pocket expenses for weight-loss drugs Zepbound and Wegovy to $200. Beginning in the second half of 2025 ...

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main rival Wegovy from Novo Nordisk. The full data from the 751-subject SURMOUNT-5 ...

Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo Nordisk, after negotiating a price cut with the company, along with Novo ...

A first of its kind report about how Individual Coverage Health Reimbursement Arrangements are perceived by both employers and benefits consultants reveals an evolving market that has plenty of ...

Both large and small employers believe they have a role to play in improving their employees’ mental, physical and financial wellbeing, according to a study by the Employee Benefit Research ...